Quent Capital’s Quest Diagnostics DGX Stock Holding History

Quent Capital’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.5K	Sell	74 -44	-37%	-$8.55K	﹤0.01%	1079
2025 Q4	$20.5K	Hold	118	–	–	﹤0.01%	985
2025 Q3	$22.5K	Buy	+118	New	+$20.9K	﹤0.01%	825
2025 Q2	–	Sell	-3	Closed	-$508	–	534
2025 Q1	$508	Hold	3	–	–	﹤0.01%	1253
2024 Q4	$453	Buy	+3	New	+$467	﹤0.01%	1277
2023 Q1	–	Sell	-10	Closed	-$1.58K	–	1331
2022 Q4	$1.58K	Sell	10 -12	-55%	-$1.72K	﹤0.01%	1178
2022 Q3	$3K	Buy	22 +12	+120%	+$1.58K	﹤0.01%	1036
2022 Q2	$1K	Buy	+10	New	+$1.36K	﹤0.01%	1094

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Quent Capital's DGX Position: Q1 2026 in Review

Quent Capital reduced its Quest Diagnostics (DGX) stake by 37% in Q1 2026, selling an estimated $8.55K and leaving 74 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1079.

Quent Capital first reported a position in DGX in Q2 2022 and has held it in 8 quarters since. The position peaked at $22.5K in Q3 2025. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Quent Capital held 74 shares of Quest Diagnostics worth $14.5K as of Q1 2026.
Quent Capital sold 44 Quest Diagnostics shares in Q1 2026, an estimated $8.55K.
Quest Diagnostics made up ﹤0.01% of Quent Capital's portfolio in Q1 2026, its #1079 holding.
Quent Capital first reported a position in Quest Diagnostics in Q2 2022 and has held it in 8 quarters since.
Quent Capital's Quest Diagnostics position peaked at $22.5K in Q3 2025.
1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.